Number of Shares
6.07 Mil
Current Holdings Value*
$209.78 Mil
% of Portfolio
72.72%
Total Estimate Gain
$26.78 Mil
% of Total Estimate Gain
10.91%

Aisling Capital Management LP's BridgeBio Pharma Inc Holding Summary

As of 2025-03-31, Aisling Capital Management LP held 6.07 Mil shares of BridgeBio Pharma Inc(BBIO), totaling $209.78 Mil. This investment constitutes 72.72% of their stock portfolio, and Aisling Capital Management LP now holds 3.2% of the outstanding BridgeBio Pharma Inc(BBIO) stock.

The initial trade took place in 2019Q2. And since then Aisling Capital Management LP has made 3 purchases of BBIO, at an average price of $40.44, for a total of 6.07 Mil shares. Based on historical transaction data and BBIO's current price of $44.86, Aisling Capital Management LP's estimated gain on his BBIO holdings is $26.78 Mil, reflecting a 10.91% gain to date.

Aisling Capital Management LP BBIO ($44.86) Holding Chart

Aisling Capital Management LP BBIO ($44.86) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1